Development of a Novel Risk-Prediction Tool for Emergency Department Patients with Symptoms of Coronary Artery

Andrew D McRae1,2, Aysha J Macci1,2, Jessalyn K Holodinsky1,2,3

  • 1Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada.

CJC Open
|June 30, 2025
PubMed

Insights

A new risk tool for chest pain patients in emergency departments can identify those unlikely to have acute coronary syndromes. This helps reduce unnecessary cardiac testing and improve healthcare efficiency.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • Over 600,000 Canadians visit the ED annually for chest pain, with 85% not having acute coronary syndromes (ACS).
  • Many low-risk patients are referred for outpatient cardiac testing, leading to low-value care and limited access for high-risk individuals.
  • Current risk tools, developed before high-sensitivity troponin assays, overestimate risk in ED patients with low troponin levels.

Purpose of the Study:

  • To derive and validate a novel risk prediction tool for emergency department patients presenting with chest pain.
  • To accurately identify low-risk patients who do not require further cardiac testing.
  • To improve the appropriate referral of chest pain patients from the ED.

Main Methods:

  • A multicentre prospective cohort study enrolling 6500 patients across 13 Canadian EDs.
  • Prospective follow-up to ascertain major adverse cardiac events (MACE) within 30 days of the index ED encounter.
  • Development and validation of a new risk prediction tool using data from enrolled patients.

Main Results:

  • The study aims to develop a tool to differentiate low-risk from potentially higher-risk chest pain patients.
  • The tool will be validated to ensure accuracy in predicting 30-day MACE.
  • Expected outcome is a reliable instrument for guiding further cardiac testing decisions.

Conclusions:

  • A novel risk prediction tool is needed to optimize the management of chest pain patients in the ED.
  • The developed tool will guide safe and efficient referral decisions, reducing unnecessary testing.
  • This will enhance healthcare resource utilization and patient access to appropriate cardiac evaluations.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
128
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
38